Yorktown, VA, United States of America

Neelam Azad

This inventor holds 1 USPTO granted patent. Top assignee: Hampton University. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neelam Azad. Retrieved from https://idiyas.com/inventor/neelam-azad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neelam Azad: Innovator in Cancer Treatment

Introduction

Neelam Azad is a prominent inventor based in Yorktown, Virginia, known for her significant contributions to cancer treatment research. As a dedicated researcher, she has focused on developing innovative methods to combat cancer through her work at Hampton University.

Latest Patents

Neelam Azad holds a patent for "Fatty acid synthase inhibitors and methods of use." This patent outlines methods for treating cancer in a subject by administering a therapeutically effective amount of an inhibitor of fatty acid synthase, or a pharmaceutically acceptable salt or prodrug thereof. This groundbreaking work has the potential to advance cancer treatment significantly.

Career Highlights

Throughout her career, Neelam has demonstrated a commitment to scientific research and innovation. Her work at Hampton University has positioned her as a key figure in the field of cancer research, where she continues to explore new therapeutic avenues.

Collaborations

Neelam Azad collaborates with esteemed colleagues such as Vivek Kaushik and Anandkrishnan Iyer, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Neelam Azad's contributions to cancer treatment through her innovative patent and collaborative efforts highlight her role as a leading inventor in the field. Her work continues to inspire advancements in medical research and treatment options for cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…